// App-Quantinova.ai

: Genomic Classifier to augment the role of pathological features in identifying optimal candidates for adjuvant radiation therapy in patients with prostate cancer: Development and internal validation of a multivariable prognostic model.

Researchers

Presenter

  • Firas Abdollah

Principal Investigators

  • Deepansh Dalela

  • Maria Santiago-Jimenez

  • Kasra Yousefi

  • Jeffrey Karnes

  • Ashley Ross

  • Robert B. Den

  • Stephen J. Freedland

  • Edward M. Schaeffer

  • Adam Dicker

  • Alberto Briganti

  • Elai Davicioni

  • Mani Menon

Medical Centers

  • Vattikuti Urology Institute, Detroit, MI

  • Henry Ford Hosp, Detroit, MI

  • GenomeDx Biosciences Inc., Vancouver, BC, Canada

  • Mayo Clinic, Rochester, MN

  • The Johns Hopkins Medical Institutions, Baltimore, MD

  • Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Sidney Kimmel Cancer Center, Philadelphia, PA.

  • Urological Research Institute, Milan, Italy

Locations

  • United States

  • Canada

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved